N alpha-(2-naphthyl-sulfonyl-glycyl)-D,L-(p-amidinophenylalanyl-piperidine)

ID: ALA1077921

Cas Number: 86845-59-2

PubChem CID: 3070748

Max Phase: Preclinical

Molecular Formula: C27H31N5O4S

Molecular Weight: 521.64

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  N=C(N)c1ccc(C[C@H](NC(=O)CNS(=O)(=O)c2ccc3ccccc3c2)C(=O)N2CCCCC2)cc1

Standard InChI:  InChI=1S/C27H31N5O4S/c28-26(29)21-10-8-19(9-11-21)16-24(27(34)32-14-4-1-5-15-32)31-25(33)18-30-37(35,36)23-13-12-20-6-2-3-7-22(20)17-23/h2-3,6-13,17,24,30H,1,4-5,14-16,18H2,(H3,28,29)(H,31,33)/t24-/m0/s1

Standard InChI Key:  XXTWZTPVNIYSJZ-DEOSSOPVSA-N

Molfile:  

     RDKit          2D

 37 40  0  0  0  0  0  0  0  0999 V2000
   17.8691  -15.2396    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.1533  -14.8271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1533  -14.0021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8691  -13.5896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5808  -14.0021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5808  -14.8271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8691  -16.0646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4416  -16.0646    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.1533  -16.4771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1533  -17.3021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8691  -17.7146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5808  -17.3021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2967  -17.7146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2967  -18.5396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5808  -18.9521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8691  -18.5396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5808  -16.4771    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.0126  -18.9521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7284  -18.5396    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.0126  -19.7771    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7257  -16.4771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2940  -16.4771    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0098  -16.0646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7257  -17.3021    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.2910  -17.3030    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   13.5806  -18.5437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5777  -17.7175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8635  -17.3093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1501  -17.7238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1510  -18.5464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4376  -18.9608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4406  -19.7870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1569  -20.1988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8702  -19.7843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8673  -18.9581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5000  -18.0958    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.0000  -16.8833    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  6  1  0
  9  8  1  6
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 11 16  2  0
  7 17  2  0
 18 19  1  0
 18 20  2  0
 14 18  1  0
  1  7  1  0
 22 23  1  0
 21 23  1  0
 21 24  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 26 35  2  0
 30 35  1  0
 25 27  1  0
 22 25  1  0
  8 21  1  0
 25 36  2  0
  1  2  1  0
 25 37  2  0
M  END

Associated Targets(non-human)

F2 Thrombin (1630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 521.64Molecular Weight (Monoisotopic): 521.2097AlogP: 2.14#Rotatable Bonds: 9
Polar Surface Area: 145.45Molecular Species: BASEHBA: 5HBD: 4
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.03CX Basic pKa: 11.43CX LogP: 1.41CX LogD: -0.49
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.25Np Likeness Score: -1.05

References

1. Thalassitis A, Hadjipavlou-Litina DJ, Litinas KE, Miltiadou P..  (2009)  Synthesis of modified homo-N-nucleosides from the reactions of mesityl nitrile oxide with 9-allylpurines and their influence on lipid peroxidation and thrombin inhibition.,  19  (22): [PMID:19811914] [10.1016/j.bmcl.2009.09.040]

Source